Which of the following are true:

• Medical education is a form of scientific exchange
• Scientific exchange must always be reactive
• Investor updates may contain off label information
• Sales representatives should not take part in scientific exchange
• Medical Information responses to scientific enquiries do not need nominated signatory review

In which of the following circumstances is there an established expectation that off label information will be shared?

• HTA submissions
• Medical Science Liaison proactive sharing of information
• Congress presentations
• Press releases to financial and investor channels
• Continuing medical education meetings

Which of the following could potentially be perceived as off label promotion?

• Sales personnel attending an advisory board
• Use of corporate branded slides at a scientific symposium
• Proactive sharing of off label information by medical science liaison staff
• Holding multiple advisory boards all about the same topic
• Speaker presentations with off label information at an AZ stand alone meeting

Advance budgetary notification must:

• Only be given if there is likely to be a significant impact on budgets
• Be given at least 3 years in advance of a launch to allow time for budget planning
• Not be directed at anticipated prescribers
• Be carried out by medical staff
• State the anticipated budget impact

Which are true about advisory boards?

• Marketing personnel should not present any slides
• Advisors should be under appropriate contracts
• These are internal meetings and so external scrutiny is not an issue
• The rationale for choice of advisors should be documented
• Time for discussion and feedback should exceed time on presentations by AZ staff